Cover Image

The acceptance to heterologous booster vaccination of COVID-19 vaccine among HCWs and targeted population: A cross-sectional study in central China

BackgroundThere are few studies reported on the acceptance of heterologous booster vaccination for the COVID-19 vaccine among healthcare workers (HCWs) and the general population. We aimed to address that gap and explore determinant factors of acceptance of the heterologous booster vaccination.Metho...

Full description

Saved in:

Bibliographic Details
Main Authors:	Wei Qin (Author), Xiaqing Zhang (Author), Yao Wang (Author), Fan Pan (Author), Kai Cheng (Author), Fangfang Huang (Author), Jian Song (Author), Hong Su (Author)
Format:	Book
Published:	Frontiers Media S.A., 2022-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A retrospective study of hepatitis B vaccination in preterm birth and low birth weight infants born to hepatitis B surface antigen-positive mothers: Time to close the policy-practice gap
by: Wei Qin, et al.
Published: (2022)

Acceptability of anti-covid -19 vaccination by health care workers (HCWs)
by: Monym Larhlid, et al.
Published: (2022)

Effectiveness of a booster dose of COVID-19 vaccines during an outbreak of SARS-CoV-2 Omicron BA.2.2 in China: A case-control study
by: Xiaqing Zhang, et al.
Published: (2023)

Effect of homologous or heterologous vaccine booster over two initial doses of inactivated COVID-19 vaccine
by: Viravarn Luvira, et al.
Published: (2024)

Emerging heterologous mRNA-based booster strategies within the COVID-19 vaccine landscape
by: Rituparna Das, et al.
Published: (2023)

Safety and immunogenicity of a heterologous booster with an RBD virus-like particle vaccine following two- or three-dose inactivated COVID-19 vaccine
by: Xiaolan Yong, et al.
Published: (2023)

Antibody dynamics for heterologous boosters with aerosolized Ad5-nCoV following inactivated COVID-19 vaccines
by: Canjie Chen, et al.
Published: (2024)

Rapid evaluation of heterologous chimeric RBD-dimer mRNA vaccine for currently-epidemic Omicron sub-variants as booster shot after inactivated vaccine
by: Qian Chen, et al.
Published: (2023)

Acceptability of the third dose of anti-SARS-CoV-2 vaccine co-administered with influenza vaccine: preliminary data in a sample of Italian HCWs
by: Pasquale Stefanizzi, et al.
Published: (2022)

Longer-term effectiveness of a heterologous coronavirus disease 2019 (COVID-19) vaccine booster in healthcare workers in Brazil
by: Alexandre R. Marra, et al.
Published: (2023)

Evidence synthesis and pooled analysis of vaccine effectiveness for COVID-19 mRNA vaccine BNT162b2 as a heterologous booster after inactivated SARS-CoV-2 virus vaccines
by: Moe H. Kyaw, et al.
Published: (2023)

Influenza vaccination in health-care workers: an evaluation of an on-site vaccination strategy to increase vaccination uptake in HCWs of a South Italy Hospital
by: Luigi Vimercati, et al.
Published: (2019)

SCB-2019 protein vaccine as heterologous booster of neutralizing activity against SARS-CoV-2 Omicron variants after immunization with other COVID-19 vaccines
by: Camilo C. Roa, et al.
Published: (2024)

Effect of an educational intervention on human papillomavirus (HPV) knowledge and attitudes towards HPV vaccines among healthcare workers (HCWs) in Western China
by: Hui Chen, et al.
Published: (2021)

Heterologous mRNA-based COVID-19 booster strategies: Comment
by: Sora Yasri, et al.
Published: (2023)

Willingness to pay for and willingness to vaccinate with the COVID-19 vaccine booster dose in China
by: Hui Jun Zhou, et al.
Published: (2022)

Breakthrough infections and acceptance of COVID-19 vaccine boosters: A survey analysis
by: Christina W. Stevens, et al.
Published: (2023)

Belief in misinformation and acceptance of COVID-19 vaccine boosters: A survey analysis
by: Stephen R. Neely, et al.
Published: (2024)

A novel heterologous receptor-binding domain dodecamer universal mRNA vaccine against SARS-CoV-2 variants
by: Shugang Qin, et al.
Published: (2023)

Heterologous Immunity: Implications and Applications in Vaccines and Immunotherapies
Published: (2020)

Heterologous Prime-boost COVID-19 Vaccination
by: Vishal R. Tandon, et al.
Published: (2021)

Association Between Risk Perception and Acceptance for a Booster Dose of COVID-19 Vaccine to Children Among Child Caregivers in China
by: Chenyuan Qin, et al.
Published: (2022)

Pivoting to protein: the immunogenicity and safety of protein-based NVX-CoV2373 as a heterologous booster for inactivated and viral vector COVID-19 vaccines
by: Anthony M. Marchese, et al.
Published: (2023)

Will People Accept a Third Booster Dose of the COVID-19 Vaccine? A Cross-Sectional Study in China
by: Yufang Sun, et al.
Published: (2022)

The level of public acceptance of vaccine booster shot / Abdul Rauf Ridzuan ... [et al.]
by: Ridzuan, Abdul Rauf, et al.
Published: (2022)

Author reply to "Heterologous mRNA-based COVID-19 booster strategies: Comment"
by: Rituparna Das, et al.
Published: (2023)

Heterologous COVID-19 vaccination in pregnant women: Comment
by: Pathum Sookaromdee, et al.
Published: (2023)

Self-Reported COVID-19 Vaccine and Booster Acceptance and Hesitancy Among Autistic Adults in Pennsylvania: Cross-Sectional Analysis of Survey Data
by: Lindsay Shea, et al.
Published: (2024)

Upgrading the school entry vaccination record check strategy to improve varicella vaccination coverage: results from a quasi-experiment study
by: Wei Qin, et al.
Published: (2021)

Immunogenicity, safety and reactogenicity of heterologous (third dose) booster vaccination with a full or fractional dose of two different COVID-19 vaccines: A phase 4, single-blind, randomized controlled trial in adults
by: Sue Ann Costa Clemens, et al.
Published: (2023)

Willingness of college students to receive COVID-19 heterologous vaccination in Taizhou, China
by: Hui Shao, et al.
Published: (2023)

Immunogenicity and reactogenicity of heterologous COVID-19 vaccination in pregnant women
by: Chenchit Chayachinda, et al.
Published: (2023)

Heterologous vaccine interventions: boosting immunity against future pandemics
by: Daniela Marín-Hernández, et al.
Published: (2021)

Ethical concerns regarding heterologous COVID-19 vaccine administration
by: Somsri Wiwanitkit, et al.
Published: (2024)

Determinants of the willingness of medical staff to vaccinate their children with a booster dose of the COVID-19 vaccine in Taizhou, China
by: Li-Li Huang, et al.
Published: (2022)

Willingness to accept a second COVID-19 vaccination booster dose among healthcare workers in Italy
by: Giorgia Della Polla, et al.
Published: (2022)

Booster Vaccination Strategies for "Living With COVID-19"
by: Jung Eun Kim, et al.
Published: (2022)

COVID-19 Vaccine Booster: To Boost or Not to Boost
by: Rahul Shekhar, et al.
Published: (2021)

A prospective cohort study protocol: monitoring and surveillance of adverse events following heterologous booster doses of Oxford AstraZeneca COVID-19 vaccine in previous recipients of two doses of Sinopharm or Sputnik V vaccines in Iran
by: Shahin Soltani, et al.
Published: (2023)

Willingness of college students to receive COVID-19 heterologous vaccination: Comment
by: Amnuay Kleebayoon, et al.
Published: (2023)